| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 43.7447 | 21 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.4455 | 24 |
| GSM780709 | Untreated after 4 days (C3_1) | 47.9021 | 41 |
| GSM780719 | Untreated after 4 days (C1_2) | 44.1101 | 23 |
| GSM780720 | Untreated after 4 days (C2_2) | 46.5311 | 35 |
| GSM780721 | Untreated after 4 days (C3_2) | 42.451 | 15 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 43.6579 | 20 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.3943 | 34 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.8813 | 41 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 44.5135 | 25 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 47.3053 | 38 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.5354 | 20 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 47.196 | 38 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 45.6966 | 31 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 42.1063 | 14 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.355 | 38 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 42.3699 | 15 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.9579 | 32 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 49.0783 | 45 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 56.4883 | 61 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.5148 | 39 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 42.1139 | 14 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 42.6162 | 16 |